Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions
Tài liệu tham khảo
Kim, 2015, Biosynthesis and biotechnological production of ginsenosides, Biotechnol Adv, 33, 717, 10.1016/j.biotechadv.2015.03.001
Lee, 2014, A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases, J Ginseng Res, 38, 161, 10.1016/j.jgr.2014.03.001
Lan, 2011, Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition, Biochem Pharmacol, 82, 148, 10.1016/j.bcp.2011.04.001
Ahmed, 2016, Ginsenoside Rb1 as a neuroprotective agent: a review, Brain Res Bull, 125, 30, 10.1016/j.brainresbull.2016.04.002
Koh, 2017, Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish, J Ginseng Res, 41, 23, 10.1016/j.jgr.2015.12.005
Zhao, 2014, Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signaling transduction factors in the NG108-15 murine neuroglial cell line, Molecules, 19, 16925, 10.3390/molecules191016925
Chen, 2016, Anticancer activities of protopanaxadiol- and protopanaxatriol-type ginsenosides and their metabolites, Evid Based Complement Alternat Med, 2016, 10.1155/2016/5738694
Xu, 2016, The antitumor activity study of ginsenosides and metabolites in lung cancer cell, Am J Transl Res, 8, 1708
Nag, 2012, Ginsenosides as anticancer agents: in vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action, Front Pharmacol, 3, 1, 10.3389/fphar.2012.00025
Choi, 2013, Biochemical basis of cancer chemoprevenion and or chemotherapy with ginsenosides, Int J Mol Med, 32, 1227, 10.3892/ijmm.2013.1519
Nabavi, 2015, Ginsenoside Rd and ischemic stroke; a short review of literatures, J Ginseng Res, 39, 299, 10.1016/j.jgr.2015.02.002
Yang, 2015, A review of biotransformation and pharmacology of ginsenoside compound K, Fitoterapia, 100, 208, 10.1016/j.fitote.2014.11.019
Jin, 2015, Ginseng consumption and risk of cancer: a meta-analysis, J Ginseng Res, 40, 269, 10.1016/j.jgr.2015.08.007
WHO fact sheet. Cardiovascular diseases (CVDs) [Internet]. 2016 September [cited 2016 Dec 29]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/.
Tousoulis, 2012, The role of nitric oxide on endothelial function, Curr Vasc Pharmacol, 10, 4, 10.2174/157016112798829760
Pirillo, 2013, LOX-1, OxLDL, and atherosclerosis, Mediators Inflamm, 2013, 152786, 10.1155/2013/152786
Hien, 2010, Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase, Toxicol Appl Pharmacol, 246, 171, 10.1016/j.taap.2010.05.008
Ganguly, 2015, Role of homocysteine in the development of cardiovascular disease, Nutr J, 14, 6, 10.1186/1475-2891-14-6
Xu, 2011, The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine, J Vasc Surg, 53, 156, 10.1016/j.jvs.2010.06.170
Yu, 2007, Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor, Biochem Biophys Res Commun, 353, 764, 10.1016/j.bbrc.2006.12.119
Ucuzian, 2010, Molecular mediators of angiogenesis, J Burn Care Res, 31, 158, 10.1097/BCR.0b013e3181c7ed82
Kwok, 2012, Stereoisomers ginsenosides-20(S)-Rg(3) and -20(R)-Rg(3) differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma, Biochem Pharmacol, 83, 893, 10.1016/j.bcp.2011.12.039
Chan, 2009, Role of MicroRNA-214 in ginsenoside-Rg1-induced angiogenesis, Eur J Pharm Sci, 38, 370, 10.1016/j.ejps.2009.08.008
Duan, 2015, MicroRNA-214 is upregulated in heart failure patients and suppresses XBP1-mediated endothelial cells angiogenesis, J Cell Physiol, 230, 1964, 10.1002/jcp.24942
Kim, 2012, Cardiovascular aiseases and Panax ginseng: a review on molecular mechanisms and medical applications, J Ginseng Res, 36, 16, 10.5142/jgr.2012.36.1.16
Heineke, 2006, Regulation of cardiac hypertrophy by intracellular signaling pathways, Nat Rev Mol Cell Biol, 7, 589, 10.1038/nrm1983
Jiang, 2007, Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat, J Ethnopharmacol, 111, 567, 10.1016/j.jep.2007.01.006
Zhang, 2013, The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis, J Cardiovasc Pharmacol, 62, 50, 10.1097/FJC.0b013e31828f8d45
Zhu, 2009, Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis, J Cell Biochem, 108, 117, 10.1002/jcb.22233
Wang, 2015, Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion injury via Akt/endothelial nitric oxide synthase signaling and the B-cell lymphoma/B-cell lymphoma-associated X protein pathway, Mol Med, 11, 4518
Wu, 2011, Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats, Mol Biol Rep, 38, 4327, 10.1007/s11033-010-0558-4
Sun, 2016, Roles and mechanisms of ginsenoside on cardiovascular diseases: progress and perspectives, Sci China Life, 59, 292, 10.1007/s11427-016-5007-8
Huang, 2012, Inhibitory effect of ginsenoside Rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation, Evid Based Complement Alternat Med, 2012, 314395, 10.1155/2012/314395
Guo, 2011, Rb1 postconditioning attenuates liver warm ischemia–reperfusion injury through ROS–NO–HIF pathway, Life Sci, 88, 598, 10.1016/j.lfs.2011.01.022
Wong, 2015, Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview, Nat Prod Rep, 32, 256, 10.1039/C4NP00080C
Lu, 2008, Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer, Chin J Integr Med, 14, 33, 10.1007/s11655-007-9002-6
Wang, 2015, Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway, Mol Med Rep, 12, 609, 10.3892/mmr.2015.3397
Shan, 2014, Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation, PLoS One, 9, e115401, 10.1371/journal.pone.0115401
Lo, 2011, Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells, J Med Food, 14, 1135, 10.1089/jmf.2010.1485
Jiang, 2011, Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway, World J Gastroenterol, 17, 3605, 10.3748/wjg.v17.i31.3605
Zhang, 2012, Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells, Mol Med Rep, 5, 1295
Zhang, 2015, 20(S)-Ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway, Drug Des Devel Ther, 9, 3969
Wu, 2015, Endoplasmic reticulum stress activation mediates Ginseng Rg3-induced anti-gallbladder cancer cell activity, Biochem Biophys Res Commun, 466, 369, 10.1016/j.bbrc.2015.09.030
Lee, 2012, Food Chem Toxicol, 50, 2565, 10.1016/j.fct.2012.01.005
Wang, 2014, 20(S)-Ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways, Tumour Biol, 35, 11985, 10.1007/s13277-014-2497-5
Junmin, 2015, Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity, J Tradit Chin Med, 35, 440
He, 2011, Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ss-catenin signaling, Int J Oncol, 38, 437, 10.3892/ijo.2010.858
Leung, 2007, Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor, Br J Pharmacol, 152, 207, 10.1038/sj.bjp.0707359
Yu, 2015, Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-β1-induced epithelial to mesenchymal transition in HepG2 cells, Mol Med Rep, 11, 3167, 10.3892/mmr.2014.3098
Steward, 2013, Cancer chemoprevention: a rapidly evolving field, Br J Cancer, 109, 1, 10.1038/bjc.2013.280
Stejskalova, 2011, The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta, Curr Pharm Biotechnol, 12, 715, 10.2174/138920111795470994
Wang, 2008, Induction of cytochrome P450 1A1 expression by ginsenoside Rg1 and Rb1 in HepG2 cells, Eur J Pharmacol, 601, 73, 10.1016/j.ejphar.2008.10.057
Li, 2016, Ginsenoside exhibits concentration-dependent dual effects on HepG2 cell proliferation via regulation of c-Myc and HNF-4α, Eur J Pharmacol, 792, 26, 10.1016/j.ejphar.2016.10.017
WHO, 2016
Yuan, 2012, Ginseng and diabetes: the evidences from in vitro, animal and human studies, J Ginseng Res, 36, 27, 10.5142/jgr.2012.36.1.27
Hwang, 2010, Ginsenoside Rb1 protects against 6-hydroxydopamine-induced oxidative stress by increasing heme oxygenase-1 expression through an estrogen receptor-related PI3K/Akt/Nrf2-dependent pathway in human dopaminergic cells, Toxicol Appl Pharmacol, 242, 18, 10.1016/j.taap.2009.09.009
Shen, 2015, Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats, Physiol Rep, 3, e12453, 10.14814/phy2.12543
Xiong, 2010, Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats, Diabetes, 59, 2505, 10.2337/db10-0315
Kong, 2009, Anti-hypoxic effect of ginsenoside Rb1 on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo, Acta Pharmacol Sin, 30, 396, 10.1038/aps.2009.2
Chen, 2016, Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue, J Ginseng Res, 40, 351, 10.1016/j.jgr.2015.11.002
Lee, 2012, Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells, Phytother Res, 26, 1017, 10.1002/ptr.3686
Kim, 2010, Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells, Biol Pharm Bull, 33, 325, 10.1248/bpb.33.325
Shang, 2008, Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes, J Endocrinol, 198, 561, 10.1677/JOE-08-0104
Kim, 2016, Rg3 improves mitochondrial function and the expression of key genes involved in mitochondrial biogenesis in C2C12 myotubes, Diabetes Metab J, 40, 406, 10.4093/dmj.2016.40.5.406
Lee, 2011, Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes, Phytother Res, 25, 768, 10.1002/ptr.3322
Kim, 2015, The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice, Sci Rep, 5, 18325, 10.1038/srep18325
Park, 2008, 20(S)-Ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK, Biol Pharm Bull, 31, 748, 10.1248/bpb.31.748
Kim, 2010, Ginsenoside 20(R)-Rg3 stimulates glucose uptake in C2C12 myotubes via CaMKK–AMPK pathways, Food Sci Biotechnol, 19, 1277, 10.1007/s10068-010-0182-z
Yu, 2016, Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model, J Cell Mol Med, 20, 623, 10.1111/jcmm.12739
Kim, 2007, Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus, Brain Res, 1136, 190, 10.1016/j.brainres.2006.12.047
Scholey, 2010, Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study, Psychopharmacology (Berl), 212, 345, 10.1007/s00213-010-1964-y
Uttara, 2009, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr Neuropharmacol, 7, 65, 10.2174/157015909787602823
Skaper, 2012, The neurotrophin family of neurotrophic factors: an overview, Methods Mol Biol, 846, 1, 10.1007/978-1-61779-536-7_1
Zheng, 2009, NMDA-mediated and self-induced bdnf exon IV transcriptions are differentially regulated in cultured cortical neurons, Neurochem Int, 54, 385, 10.1016/j.neuint.2009.01.006
Liang, 2010, Ginsenosides Rb1 and Rg1 promote proliferation and expression of neurotrophic factors in primary Schwann cell cultures, Brain Res, 1357, 19, 10.1016/j.brainres.2010.07.091
Shi, 2010, Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice, J Alzheimers Dis, 19, 977, 10.3233/JAD-2010-1296
Jiang, 2012, Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus, Br J Pharmacol, 166, 1872, 10.1111/j.1476-5381.2012.01902.x
Ardah, 2015, Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils, Neurobiol Dis, 74, 89, 10.1016/j.nbd.2014.11.007
O'Brien, 2011, Amyloid precursor protein processing and Alzheimer's disease, Annu Rev Neurosci, 34, 185, 10.1146/annurev-neuro-061010-113613
Chen, 2008, Involvement of calpain and p25 of CDK5 pathway in ginsenoside Rb1's attenuation of beta-amyloid peptide25-35-induced tau hyperphosphorylation in cortical neurons, Brain Res, 1200, 99, 10.1016/j.brainres.2007.12.029
Shi, 2012, Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt, Biochim Biophys Acta, 1820, 453, 10.1016/j.bbagen.2011.12.005
Araki, 2016, Post-translational regulation of the β-secretase BACE1, Brain Res Bull, 126, 170, 10.1016/j.brainresbull.2016.04.009
Choi, 2016, BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides, J Ethnopharmacol, 190, 219, 10.1016/j.jep.2016.06.013
Chen, 2012, Ginsenoside Rg1 attenuates beta-amyloid generation via suppressing PPARgamma-regulated BACE1 activity in N2a-APP695 cells, Eur J Pharmacol, 675, 15, 10.1016/j.ejphar.2011.11.039
Wu, 2013, Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway, Neurochem Int, 62, 92, 10.1016/j.neuint.2012.09.016
Liu, 2014, Neuroprotective effects of ginsenoside Rb1 on hippocampal neuronal injury and neurite outgrowth, Neural Regen Res, 9, 943, 10.4103/1673-5374.133137
Hao, 2011, Beneficial estrogen-like effects of ginsenoside Rb1, an active component of Panax ginseng, on neural 5-HT disposition and behavioral tasks in ovariectomized mice, Eur J Pharmacol, 659, 15, 10.1016/j.ejphar.2011.03.005
Lau, 2008, Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway, J Steroid Biochem Mol Biol, 108, 64, 10.1016/j.jsbmb.2007.06.005
Shohami, 2014, Novel approach to the role of NMDA receptors in traumatic brain injury, CNS Neurol Disord Drug Targets, 13, 567, 10.2174/18715273113126660196
Zhang, 2008, Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels, Eur J Pharmacol, 586, 90, 10.1016/j.ejphar.2007.12.037
Shen, 2007, NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils, Neurol Res, 29, 270, 10.1179/016164107X159144
Yang, 2014, Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice, J Gerontol A Biol Sci Med Sci, 69, 282, 10.1093/gerona/glt091
Escobar, 2004, Neuropeptide Y gene expression is increased in the hypothalamus of older women, J Clin Endocrinol Metab, 89, 2338, 10.1210/jc.2003-031899
Gumbs, 2016, The effect of obesogenic diets on brain Neuropeptide Y, Physiol Behav, 162, 161, 10.1016/j.physbeh.2016.04.049
Lin, 2014, Ginseng panaxoside Rb1 reduces body weight in diet-induced obese mice, Cell Biochem Biophys, 68, 189, 10.1007/s12013-013-9688-3
Ye, 2016, Neuroprotective effects of ginsenosides on neural progenitor cells against oxidative injury, Mol Med Rep, 13, 3083, 10.3892/mmr.2016.4914
Ni, 2014, Ginsenoside Rb1 protects rat neural progenitor cells against oxidative injury, Molecules, 19, 3012, 10.3390/molecules19033012
Tabas, 2011, Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress, Nat Cell Biol, 13, 184, 10.1038/ncb0311-184
Liu, 2014, Ginsenoside Rb1 protects hippocampal neurons from high glucose-induced neurotoxicity by inhibiting GSK3beta-mediated CHOP induction, Mol Med Rep, 9, 1434, 10.3892/mmr.2014.1958
Liu, 2013, Neuroprotective effects of ginsenoside Rb1 on high glucose-induced neurotoxicity in primary cultured rat hippocampal neurons, PLoS One, 8, e79399, 10.1371/journal.pone.0079399